Magden, Switzerland

Rainer Mussmann

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Evotec International Gmbh. Active years: 2015.

USPTO Granted Patents = 1 


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rainer Mussmann: Innovator in Pharmaceutical Conjugates

Introduction

Rainer Mussmann is a notable inventor based in Magden, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on neurturin conjugates. His research focuses on enhancing the bioavailability of pharmaceutical products, which is crucial for effective treatment options.

Latest Patents

Rainer Mussmann holds a patent for "Neurturin conjugates for pharmaceutical use." This invention relates to neurturin protein products that are conjugated to polyols. The pharmaceutical compositions comprising these neurturin conjugates, especially PEGylated variants, demonstrate increased bioavailability, making them valuable in medical applications.

Career Highlights

Throughout his career, Rainer has worked with prominent organizations, including Evotec International GmbH and Technische Universität Braunschweig. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Rainer has collaborated with notable colleagues such as Thomas Siegmund and Martin Schneider. These partnerships have further enriched his work and expanded the impact of his inventions in the pharmaceutical industry.

Conclusion

Rainer Mussmann's innovative contributions to pharmaceutical science, particularly through his patent on neurturin conjugates, highlight his role as a key inventor in the field. His work continues to influence advancements in drug formulation and bioavailability.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…